JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M200086200 on March 6, 2002

J. Biol. Chem., Vol. 277, Issue 20, 17804-17810, May 17, 2002
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/20/17804    most recent
M200086200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Eto, K.
Right arrow Articles by Takada, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Eto, K.
Right arrow Articles by Takada, Y.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Functional Classification of ADAMs Based on a Conserved Motif for Binding to Integrin alpha 9beta 1

IMPLICATIONS FOR SPERM-EGG BINDING AND OTHER CELL INTERACTIONS*

Koji EtoDagger , Clotilde Huet§, Takehiko TaruiDagger , Sergey Kupriyanov§, Hai-Zhen Liu§, Wilma Puzon-McLaughlinDagger , Xi-Ping ZhangDagger , Dean Sheppard, Eva Engvall§, and Yoshikazu TakadaDagger ||

From the Dagger  Department of Cell Biology, The Scripps Research Institute, La Jolla, California 92037, § The Burnham Institute, La Jolla, California 92037, and the  Lung Biology Center, Center for Occupational and Environmental Health, Cardiovascular Research Institute, and Department of Medicine, University of California, San Francisco, California 94143

Received for publication, January 4, 2002, and in revised form, February 22, 2002

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

ADAMs (a disintegrin and metalloproteases) are members of the metzincin superfamily of metalloproteases. Among integrins binding to disintegrin domains of ADAMs are alpha 9beta 1 and alpha vbeta 3, and they bind in an RGD-independent and an RGD-dependent manner, respectively. Human ADAM15 is the only ADAM with the RGD motif in the disintegrin domain. Thus, both integrin alpha 9beta 1 and alpha vbeta 3 recognize the ADAM15 disintegrin domain. We determined how these integrins recognize the ADAM15 disintegrin domain by mutational analysis. We found that the Arg481 and the Asp-Leu-Pro-Glu-Phe residues (residues 488-492) were critical for alpha 9beta 1 binding, but the RGD motif (residues 484-486) was not. In contrast, the RGD motif was critical for alpha vbeta 3 binding, but the other residues flanking the RGD motif were not. As the RX6DLPEF alpha 9beta 1 recognition motif (residues 481-492) is conserved among ADAMs, except for ADAM10 and 17, we hypothesized that alpha 9beta 1 may recognize disintegrin domains in all ADAMs except ADAM10 and 17. Indeed we found that alpha 9beta 1 bound avidly to the disintegrin domains of ADAM1, 2, 3, and 9 but not to the disintegrin domains of ADAM10 and 17. As several ADAMs have been implicated in sperm-oocyte interaction, we tested whether the functional classification of ADAMs, based on specificity for integrin alpha 9beta 1, applies to sperm-egg binding. We found that the ADAM2 and 15 disintegrin domains bound to oocytes, but the ADAM17 disintegrin domain did not. Furthermore, the ADAM2 and 15 disintegrin domains effectively blocked binding of sperm to oocytes, but the ADAM17 disintegrin domain did not. These results suggest that oocytes and alpha 9beta 1 have similar binding specificities for ADAMs and that alpha 9beta 1, or a receptor with similar specificity, may be involved in sperm-egg interaction during fertilization. As alpha 9beta 1 is a receptor for many ADAM disintegrins and alpha 9beta 1 and ADAMs are widely expressed, alpha 9beta 1-ADAM interaction may be of a broad biological importance.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

ADAMs1 (a disintegrin and metalloproteases) or MDC (metalloprotease/disintegrin/cysteine-rich) proteins are a family of transmembrane glycoproteins of more than 30 members (see www.people.virginia.edu/~jag6n/Table_of_the_ADAMs.html and www.gene.ucl.ac.uk/nomenclature/genefamily/metallo. html). ADAMs have a prodomain, a metalloprotease domain, a disintegrin domain, a cysteine-rich region, an EGF-like domain, a transmembrane domain, and a cytoplasmic tail (1-3). Several ADAMs are involved in crucial biological processes such as fertilization (ADAM1, 2, and 3) (4-6) and muscle cell differentiation (meltrin-alpha , ADAM12) (7, 8). Most, but not all, ADAMs have a catalytically active metalloprotease domain, which processes several biologically important cell surface proteins including tumor necrosis factor-alpha (tumor necrosis factor converting enzyme (TACE), ADAM17) (for reviews, see Refs. 9 and 10), Alzheimer protein precursor (ADAM10 and 17) (11, 12), Delta (ADAM10) (9, 13, 14), and heparin-binding EGF (ADAM9) (15).

The ADAM disintegrin domains are homologous to snake venom disintegrins and are potential integrin ligands. Snake venom disintegrins bind to the platelet integrin alpha IIbbeta 3 in an RGD-dependent manner. Of all known ADAMs, ADAM15 is the only one that has the RGD motif in the disintegrin domain. Indeed, as we have reported, the ADAM15 disintegrin domain binds to integrin alpha vbeta 3 in an RGD-dependent manner (16). However, ADAM15 binds also to alpha 9beta 1 in an RGD-independent manner (17) and to integrin alpha 5beta 1 (18). Several laboratories, including ours, have reported that the non-RGD ADAM disintegrin domains interact with several integrins such as ADAM2 and 9 with alpha 6beta 1 (5, 19), ADAM12 with alpha 9beta 1(17), ADAM23 with alpha vbeta 3 (20), and ADAM28 with alpha 4beta 1 (21).

At least three ADAMs have been shown to participate in fertilization (ADAM1, 2, and 3) (Refs. 5 and 22, and for review, see Ref. 23). The ADAMs on the sperm surface are processed and lack the pro- and metalloprotease domains; thus the disintegrin domains of ADAMs may be the most important in sperm-egg binding. Recent reports showed that several amino acid residues within the putative integrin-binding loop of the ADAM disintegrin domain are critical for sperm-egg interaction (24-26). The identity of the integrin(s) to which the disintegrin domains bind has not been fully established. As antibodies to integrin alpha 6 were shown to block sperm-egg binding, it has been proposed that integrin alpha 6beta 1 on the egg binds to ADAM2 and 3 on the sperm (26). However, oocytes from alpha 6-null mice can be fertilized in vitro (27), and anti-integrin alpha 6 subunit monoclonal antibody does not always block sperm binding (28). Thus, it is still unclear whether alpha 6beta 1 is the main or only integrin involved in sperm-egg interaction, and the specificity, occurrence, and significance of integrin-ADAM binding in other cells and tissues are not known (for review, see Ref. 23).

In the present study, we analyzed how integrins alpha vbeta 3 and alpha 9beta 1 recognize the ADAM15 disintegrin domain by mutating amino acid residues in the putative integrin-binding site of the disintegrin domain (Fig. 1a). We found that alpha vbeta 3 and alpha 9beta 1 recognize distinct motifs in the disintegrin domain, the RGD (residues 484-486) and the RX6DLPEF (residues 481-492) motifs, respectively. The RX6DLPEF alpha 9beta 1 recognition motif is conserved among ADAMs, except for ADAM10 and 17, and we provide evidence that alpha 9beta 1 recognizes several, perhaps all, ADAM disintegrins with this motif. We also found that oocytes and alpha 9beta 1 have similar binding specificities for ADAM disintegrin domains and propose that alpha 9beta 1, or a receptor with similar specificity, may be involved in sperm-oocyte interaction during fertilization. Considering that alpha 9beta 1 and ADAMs are widely expressed, alpha 9beta 1-ADAM interactions may have a broad significance in many biological and pathological processes such as fertilization, development, and tissue remodeling.

    MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Production of Recombinant Disintegrin Domains as Glutathione S-Transferase (GST) Fusion Proteins-- Complementary DNA fragments encoding the disintegrin domain of ADAMs were amplified by polymerase chain reaction and cloned in a pGEX-2T vector (Amersham Biosciences) as described previously (16). The disintegrin domains were derived from mouse ADAM1 (Arg246-Gln334), mouse ADAM2 (Lys388-Pro479), mouse ADAM3 (Gly394-Glu486), human ADAM9 (Ser413-Tyr503), mouse ADAM10 (Gly457-Thr554), human ADAM15 (Met420-Glu510), mouse ADAM15 (Met421-Glu511), and mouse ADAM17 (Ser474-Thr565). GST fusion proteins were produced and purified as described previously (16). Absorbance at 280 nm was measured to determine the concentration of purified proteins, and the amount of proteins was calculated as described previously (16). In some experiments, because GST binds to the egg plasma membrane (24), disintegrin domains used for bead coating (see below) were released from the GST by incubating with thrombin (1 unit/mg of protein) for 6 h at room temperature, and the free GST was removed by glutathione-agarose affinity chromatography.

Chinese Hamster Ovary (CHO) Cell Adhesion Assays-- CHO cells expressing alpha vbeta 3, human alpha 6, or human alpha 9 (designated beta 3-, alpha 6-, or alpha 9-CHO cells, respectively) have been described elsewhere (17). Adhesion assays were performed as described previously (16). Briefly, wells of 96-well Immulon-2 microtiter plates (Dynatech Laboratories, Chantilly, VA) were coated with substrates in 100 µl of PBS (10 mM phosphate buffer, 0.15 M NaCl, pH 7.4) overnight at 4 °C. Remaining protein-binding sites were blocked by incubating with 1% bovine serum albumin (BSA) (Calbiochem) for 1 h at room temperature. After washing with PBS, CHO cells (105 cells/well) in 100 µl of Dulbecco's modified Eagle's medium supplemented with 1% BSA were added to the wells and incubated at 37 °C for 1 h. After unbound cells were removed by rinsing the wells with Dulbecco's modified Eagle's medium, bound cells were quantified by measuring endogenous phosphatase activity (29).

Gamete Preparation for in Vitro Binding Assays-- Three-week-old B6129PF1/J female mice (Jackson Laboratory) were superovulated using standard hormonal treatment. Oocytes were collected 12-13 h after administration of human chorionic gonadotrophin, and cumulus cells were removed by incubation with hyaluronidase in Flushing and Holding medium (Specialty Media) for 5 min at 37 °C. The zona pellucida were softened in Flushing and Holding medium containing 10 µg/ml alpha -chymotrypsin (Sigma) and then removed by passing the eggs through a narrow pipette as described previously (5). Zona pellucida-free eggs were allowed to recover in fertilization medium composed of Human Tubal Fluid medium (Irvine Scientific) supplemented with 5 mg/ml BSA fraction V (Sigma) for 1-2 h at 37 °C under mineral oil in a 5% CO2 atmosphere.

Sperms were collected from 3-6-month-old B6129F1 male mice (Taconic Farms) by placing the cauda of the epididymis and the vas deferens in 1 ml of fertilization medium under mineral oil. Each tissue was slit open with the edge of an injection needle. Sperms were allowed to swim out for 20 min at 37 °C in an atmosphere of 5% CO2. Tissues were removed from the medium, and spermatozoa were capacitated for 2-3 h under the same conditions. The sperm concentration was estimated with a hemocytometer.

Binding of Disintegrin-coated Beads to Eggs-- Fluorescent beads (0.2-µm yellow-green sulfate microspheres, Molecular Probes, Inc.) were coated overnight at 4 °C with purified GST-free disintegrin domains (0.3 mg/ml), washed with PBS, quenched for 1 h at 4 °C in fertilization medium containing 3% BSA, and resuspended by sonication with a water bath sonicator just before use. Zona pellucida-free eggs were incubated in 25-µl drops of 0.1% (v/v) coated beads in 3% BSA in fertilization medium under mineral oil for 1 h at 37 °C in a 5% CO2 atmosphere. Eggs were then washed three times with fertilization medium, fixed in 0.5% glutaraldehyde, and analyzed by confocal microscopy (Bio-Rad, MRC 1024). To confirm that beads were coated with equal amounts of recombinant protein, aliquots of coated beads were boiled in Laemmli SDS sample buffer and subjected to SDS-polyacrylamide gel electrophoresis followed by staining with Coomassie Blue.

Sperm-Egg Binding Assay-- Zona pellucida-free eggs were preincubated with GST fusion proteins in 100-µl drops of fertilization medium under mineral oil for 30 min at 37 °C in a 5% CO2 atmosphere. The concentration of GST elution buffer (100 mM Tris, 5 mM reduced glutathione) was adjusted to 10% (v/v) final concentration. Sperm was then added into the drops (2.5 × 105 sperm/ml final concentration) and incubated for 1 h. Eggs were washed by removing medium from the drop and adding fresh Flushing and Holding medium three times. Finally eggs were fixed by adding glutaraldehyde to the drops to a final concentration of 0.5%. The number of spermatozoa bound to each egg was counted immediately under a microscope. Aliquots of the GST fusion proteins used were subjected to SDS-PAGE under reducing conditions, transferred onto nitrocellulose membrane, and stained with Ponceau S to confirm the amount and the quality of recombinant proteins at the end of the incubation. Control in vitro fertilization was routinely performed at ~50 × 106 sperm/ml to ascertain the quality of gametes and to verify that more than 90% of the eggs could be fertilized.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Integrins alpha vbeta 3 and alpha 9beta 1 Bind to Distinct Motifs in the Disintegrin Domain of ADAM15-- Human ADAM15 is the only ADAM with the RGD motif within the putative integrin-binding sites of disintegrin domains (Fig. 1a). We have reported that alpha vbeta 3 and alpha 9beta 1 recognize the ADAM15 disintegrin domain in an RGD-dependent and an RGD-independent manner, respectively (17). To identify how different integrins recognize the ADAM15 disintegrin domain, we introduced mutations around the RGD motif. The mutant ADAM15 disintegrin domains were synthesized in bacteria as GST fusion proteins. The ability of the mutant disintegrin domains to bind to alpha vbeta 3 and alpha 9beta 1 was determined in cell adhesion assays with CHO cells expressing recombinant alpha vbeta 3 or alpha 9beta 1 (designated beta 3-CHO cells and alpha 9-CHO cells, respectively). CHO cells transfected with expression vector (designated mock-CHO cells) were used as controls. CHO cells express endogenous alpha vbeta 1, alpha vbeta 5, and alpha 5beta 1 (30), but these integrins do not bind to ADAM15 (16).


View larger version (32K):
[in this window]
[in a new window]
 
Fig. 1.   Effect of point mutations on binding of cells expressing alpha 9beta 1 (b-d) or alpha vbeta 3 (b, e, and f) to the disintegrin domain of human ADAM15. a shows the position of the RGD motif in the putative integrin-binding region in the disintegrin domain of human ADAM15. Mutant disintegrin-GST fusion protein was generated in bacteria, and the disintegrin domain was cleaved and purified as described under "Materials and Methods." Adhesion of alpha 9- and beta 3-CHO cells was tested as a function of the coating concentration of the disintegrin domain. TM, transmembrane.

Fig. 1b shows that mutating the RGD motif to SGA completely blocked the binding of alpha vbeta 3 but had no detectable effect on the binding of alpha 9beta 1 to the ADAM15 disintegrin domain, consistent with the previous report (17). We found that the R481A, C487A, D488A, L489A, E491, and F492A mutations negatively affected adhesion of alpha 9-CHO cells to the ADAM15 disintegrin domain (Fig. 1, c and d). In contrast, the same mutations flanking the RGD motif did not significantly affect adhesion of beta 3-CHO cells to the ADAM15 disintegrin domain (Fig. 1, e and f). Mutating the Asp488 and Glu491 simultaneously did not further affect the adhesion of alpha 9- or beta 3-CHO cells to the ADAM15 disintegrin domain (Fig. 1, d and f). Altogether these results show that the alpha vbeta 3-ADAM15 interaction requires the RGD motif but not the surrounding residues. Thus, alpha vbeta 3 and alpha 9beta 1 recognize ADAM15 in distinct manners. Interestingly the residues critical for alpha 9beta 1 binding in the disintegrin domain, including Asp488, have also been identified as critical for sperm-egg binding in ADAM2 and 3 (24-26). The sperm-egg binding studies were performed without reference to any specific integrin, but the results are compatible with alpha 9beta 1 being the oocyte receptor.

The alpha 9beta 1 binding motif in ADAM15 is conserved in many ADAMs. The alignment of the sequences of the putative integrin-binding regions of several ADAM disintegrin domains is shown in Fig. 2a. The Arg481, Asp488, Leu489, Pro490, Glu491, and Phe492 residues that are critical for alpha 9beta 1 binding in ADAM15 (designated the RX6DLPEF motif) are conserved among the disintegrin domains of all mammalian ADAMs except for ADAM10, which has the sequence RX5AREGI, and ADAM17, which has the sequence QX7KGVSY, in this region. We thus hypothesized that alpha 9beta 1 is a common receptor for many, if not all, ADAM disintegrin domains with this motif. To address this hypothesis, we tested the disintegrin domains of several ADAMs for interaction with alpha 9beta 1 in cell attachment assays (Fig. 2, b and c). We found that alpha 9-CHO cells adhered to the disintegrin domains from ADAM1, 2, 3, and 9 as well as 15 used as a positive control. alpha 9-CHO cells do not spread very well on these disintegrins. The alpha 9-CHO cells did not significantly adhere to the disintegrin domains from ADAM10 or 17. Control mock-transfected CHO cells did not significantly adhere to any of the ADAMs tested. We further found that adhesion of alpha 9-CHO cells to the ADAMs was completely blocked by anti-alpha 9 monoclonal antibody Y9A2 (data not shown), showing that the adhesion was alpha 9-specific. These results indicate that alpha 9beta 1 may be a common receptor for ADAM disintegrin domains with the RX6DLPEF-like motif.


View larger version (53K):
[in this window]
[in a new window]
 
Fig. 2.   Interaction between alpha 9beta 1 and ADAMs disintegrin domains. a, alignment of the putative integrin-binding sites of different ADAM disintegrin domains. Amino acid residues that are critical for alpha 9beta 1 interaction are boxed. h, m, and rADAMs represent human, mouse, and rat ADAMs, respectively. ADAMs that have been identified in nonmammalian species (ADAM13, 14, and 16) are not shown. It should be noted that the critical residues are not conserved in ADAM10 and ADAM17. b and c, adhesion of alpha 9-CHO cells to GST-ADAM disintegrin domains. GST-ADAM1, -ADAM2, -ADAM3, -ADAM9, and -ADAM15 disintegrin domains support adhesion of alpha 9-CHO cells, but those of -ADAM10 and -ADAM17 do not.

Since alpha 6beta 1 has been implicated in ADAM2 and ADAM3 binding (26), we tested whether alpha 6beta 1 expressed in CHO cells bound to the ADAM2 and 3 disintegrin domains. We found that alpha 6beta 1 did not mediate adhesion of alpha 6-CHO cells to ADAM2 and 3 under the conditions in which alpha 9-CHO cells adhered to these ligands (data not shown).

Interaction of Oocytes with Disintegrin Domains of ADAMs-- Several residues in the putative integrin-binding region of ADAM1, 2, and 3 have been identified as critical for sperm-egg binding (24-26), but it has not been established which receptor(s) may be involved. Since ADAM1, 2, and 3 disintegrins bind avidly to alpha 9beta 1, we wanted to test whether the binding of sperm to the oocyte may have a specificity similar to disintegrin binding to alpha 9beta 1. To address this hypothesis, we first studied whether the recombinant ADAM disintegrin domains interact with oocytes. Although ADAM15 and 17 have not been shown to be present on sperm, they were used to test specificity.

We tested whether fluorescent beads coated with disintegrin domains of ADAM2, 15, and 17 bind to zona pellucida-free eggs. As GST alone binds to such eggs (24), the GST portion of the recombinant fusion proteins was cleaved off, and the recombinant GST-free disintegrin domains were purified prior to coating of the beads. Fig. 3 shows that the beads coated with the ADAM15 disintegrin domain bound efficiently to the oocytes, the binding being largely concentrated to the microvillar region of the egg (Fig. 3b, inset). ADAM2 disintegrin domain-coated beads also bound to the egg microvillar region (Fig. 3a) but to a lesser extent than ADAM15-coated beads. Beads coated with the ADAM17 disintegrin domain (Fig. 3c) and BSA-coated beads (not shown) did not bind to eggs.


View larger version (61K):
[in this window]
[in a new window]
 
Fig. 3.   Binding of disintegrin domains to the egg microvillar region. Fluorescent microspheres were coated with 0.3 mg/ml GST-free recombinant disintegrin domains of mouse ADAM2 (a), ADAM15 (b), and ADAM17 (c) and incubated with zona pellucida-free eggs. Bead binding was analyzed by confocal microscopy after washing. Left panel, phase contrast image. Right panel, projection of fluorescence images in a single plane. Pictures show results from one representative experiment of three. ADAM15- and to a lesser extent ADAM2-coated beads bound to the microvillar region (b, inset) of all eggs, while ADAM17-coated beads did not bind significantly. Scale bar, 100 µm.

We next tested whether recombinant disintegrin domains, used as GST fusion proteins, would inhibit the binding of sperm to oocytes. The disintegrin domains from ADAM2 and ADAM15 inhibited the binding of sperm to mouse eggs in a dose-dependent manner, whereas that from ADAM17 did not affect sperm-egg binding (Fig. 4). The ADAM15 disintegrin domain was a more potent inhibitor than the ADAM2 disintegrin domain, blocking sperm-egg binding completely at 3 µM. Consistent with previous reports, the ADAM2 disintegrin domain at 3 µM inhibited sperm-egg binding to about 50%. Altogether, these results indicate that the binding specificity of sperm for the oocyte is similar to that of ADAM disintegrin for integrin alpha 9beta 1.


View larger version (19K):
[in this window]
[in a new window]
 
Fig. 4.   The disintegrin domain of ADAM15 inhibits the binding of sperm to the egg plasma membrane. The disintegrin domains produced as GST fusion proteins were tested for their ability to interfere with the in vitro binding of capacitated sperm to zona pellucida-free eggs. Data represent means ± S.E. (n = 18-21) from one representative experiment of three.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

We have shown here that the conserved RX6DLPEF motif flanking the RGD motif in the ADAM15 disintegrin domain, but not the RGD motif itself, is important for binding of ADAM15 to alpha 9beta 1. The ADAM disintegrin domains with this motif, e.g. those of ADAM1, 2, 3, 9, 12, and 15, bind avidly to alpha 9beta 1, but those lacking this motif, ADAM10 and 17, do not. The RX6DLPEF motif is conserved among all ADAM disintegrin domains except ADAM10 and 17 (Fig. 2a), suggesting that alpha 9beta 1 is a receptor for all ADAMs with this recognition motif and that binding of ADAM disintegrin domains to alpha 9beta 1 through this motif may have critical biological functions. ADAM10 and 17 represent a subfamily within the ADAM family with several distinct structural (and functional) features. The disintegrin domains of ADAM10 and 17 contain only 13 of the 15 cysteine residues characteristic of a typical type III snake venom disintegrin domain, indicating that the disintegrin function of ADAM10 and 17 may be different from those of ADAMs with the conserved RX6DLPEF motif as well as from that of snake venom disintegrins and may not bind to any integrin at all.

The RGD motif is not important for alpha 9beta 1 binding to ADAM15. Thus, alpha 9beta 1 recognizes ADAM15 in a manner distinct from that of alpha vbeta 3. Human ADAM15 is the only ADAM with the RGD motif in the disintegrin domain, and the RGD motif is not conserved among ADAM disintegrin domains (even mouse ADAM15 does not have this motif), suggesting that RGD-dependent interaction of ADAM15 with integrins may have only limited importance. This is in stark contrast to many snake venom disintegrins in which the RGD motif is highly conserved. Snake venom disintegrins bind to alpha IIbbeta 3 or alpha vbeta 3 integrins and block thrombosis and hemostasis (for reviews, see Refs. 2 and 31).

The three-dimensional structures of the snake venom disintegrins echistatin (Protein Data Bank code 2ECH) and kistrin (1KST) are available. The "disintegrin loops" of echistatin and kistrin are protruding loops (approximately 15 Å long and 4 Å wide) with the RGD motif at the tip of the loops. The three-dimensional structure of the ADAM disintegrin is not available. We generated a molecular model of the "disintegrin loop region" of the ADAM15 disintegrin domain based on the echistatin structure (2ECH) using the SWISS-MODEL protein modeling server (Fig. 5) assuming that the ADAM disintegrin and snake venom disintegrins are similar in structure. In this model oppositely charged residues (Arg481 and Glu491, Arg484 and Asp488) and hydrophobic residues (Pro482 and Pro490) are close to each other, stabilizing the loop. This model predicts that the Arg481 and the DLPEF motif in the alpha 9beta 1 binding motif are located on the opposite side of the loop and that Arg481 and Glu491 are close to each other in space, although they are distant from each other in the primary structure. The RGD motif is present at the tip of the loop. It is likely that the entire loop sequence may be required for synthetic peptides of the ADAM disintegrins to be properly folded and effectively bind to alpha 9beta 1.


View larger version (24K):
[in this window]
[in a new window]
 
Fig. 5.   A model of the integrin-binding site of ADAM15 disintegrin domain based on the echistatin structure (2ECH). This model was generated using the SWISS-MODEL protein modeling server (36-38). The alignment used for generating the model is shown. The amino acid residues that are critical for alpha 9beta 1 binding are shown in bold.

alpha 9beta 1 has been shown to mediate cell adhesion and migration but not cell spreading in vitro. The association of an adhesion receptor, such as alpha 9beta 1, with a metalloprotease, such as an ADAM, would be expected to facilitate cell migration in vivo in that the protease may digest and modify extracellular matrices and other tissue barriers in the immediate area of adhesion. The association between alpha 9beta 1 and ADAM would further be expected to occur between molecules on the same cell, i.e. in cis, as cell-cell interaction is not normally a feature of cell migration. In contrast, it has been proposed that shedding of growth factors occurs with the growth factor and ADAM expressed on different cells, i.e. in trans. ADAM9 is responsible for processing of heparin-binding EGF (15) and binds with high affinity to integrin alpha 9beta 1 (the present report). It will be interesting to know whether integrin alpha 9beta 1 is involved in the processing of heparin-binding EGF. Our identification of mutations that obliterate the binding of alpha 9beta 1 to ADAMs can now be used to test the role of alpha 9beta 1-ADAM binding on cell migration as well as on processing of heparin-binding EGF and other potential ADAM substrates. As the prominent sheddases ADAM10 and 17 do not bind to alpha 9beta 1, it is unlikely that alpha 9beta 1 is involved in the processing of the proteins they target, including tumor necrosis factor-alpha and the Alzheimer precursor protein. Few ADAMs other than ADAM10 and 17 have been tested for capacity to process these proteins. It is possible that the specificities of the ADAM domains other than the metalloprotease domains and the cell type-specific expression of ADAM ligands, such as integrin alpha 9beta 1, will determine which proteins will be digested and when. The digestion may then occur either in cis or in trans depending on the situation. The metalloprotease domains themselves may be rather nonspecific. The relative nonspecificity of metalloproteases agrees with the lack of success in developing specific metalloprotease inhibitors despite a large effort in this area by the pharmaceutical companies.

As many ADAMs that have the RX6DLPEF motif are present on sperm (5) and ADAMs have been implicated in sperm-egg binding during fertilization, we tested whether alpha 9beta 1-ADAM interaction may be involved in sperm-egg binding. Two recent studies demonstrate that the presence of acidic residues surrounding the cysteine in the disintegrin loop of ADAM2 (X(C/D)ECD) is essential for the binding of ADAM2 to the egg plasma membrane (24, 25). The underlined residues correspond to the RGD sequence in ADAM15. ADAM3, which also plays a role in sperm-egg binding, has the same characteristics in the sequence of its disintegrin loop (KSDCD). It has also been reported that synthetic peptides of the ADAM2 and 3 disintegrin domain putative integrin-binding site block sperm-egg interaction (5, 22, 24, 26). It is intriguing that the RX6DLPEF alpha 9beta 1 recognition motif is overlapping with these peptide sequences. All studies to date show that the Asp residue is essential. This residue is not conserved in ADAM10 and 17.

We have shown here that the disintegrin domains of ADAM2 and 15, which effectively bind to integrin alpha 9beta 1, bound to murine oocytes and blocked sperm-egg binding, but the ADAM17 disintegrin domain, which does not bind to alpha 9beta 1, did not. Although ADAM15 has not been shown to be present on sperm, it shares the specificity with the sperm ADAM2; in fact, in our experiments, ADAM15 was more effective in egg binding and inhibition of sperm-egg binding that ADAM2, although these differences may be primarily technical. These binding studies suggest that the receptor for sperm on the oocytes is similar in specificity to alpha 9beta 1. These results are well explained if eggs express integrin alpha 9beta 1 on their surface. Although we confirmed the expression of alpha 9beta 1 in many mouse tissues (32-34), our efforts to identify alpha 9 on oocytes, using immunostaining in mouse ovary with anti-alpha 9 cytoplasmic peptide antibody 1057 or in guinea pig ovary with either antibody 1057 or monoclonal antibody Y9A2, were not successful. The lack of detection of alpha 9 in the ovary suggests that either alpha 9 is not present or it is not accessible to antibodies. Another integrin(s) or other receptor with specificity similar to alpha 9beta 1 may exist in eggs.

It has been proposed that alpha 6beta 1 is the oocyte receptor for sperm (5). Recent findings that sperm-egg interaction is normal in alpha 6-null mice (27) and that the antibody to alpha 6, GoH3, does not always affect sperm-egg interaction (28, 35) have raised questions about the role of alpha 6beta 1 in sperm-egg binding and fusion. We thus tested the ability of alpha 6beta 1 to bind to the ADAM disintegrin domains. We did not detect adhesion of alpha 6-expressing CHO cells to the ADAM disintegrins under the conditions in which alpha 9-CHO cells adhere to the same ligands. However, it cannot be ruled out that alpha 6beta 1 may interact with the ADAM disintegrin domains under certain conditions in oocytes. Since we used CHO cells expressing human alpha 9 or alpha 6/hamster beta 1 hybrid in this study, it also cannot be ruled out that human and hamster beta 1 provide different ligand specificities.

The biological significance of the interaction between ADAMs and alpha 9beta 1 integrin is not known. alpha 9beta 1 is present in many developing and mature tissues including airway epithelia, the basal layer of squamous epithelia, smooth muscle, skeletal muscle, hepatocytes, neutrophils, and monocytes (32-34). Considering the wide distribution of both ADAMs and alpha 9beta 1, ADAM-alpha 9beta 1 interactions may play a role in many physiological and pathological situations including muscle development and regeneration; vascular, cartilage, and other tissue remodeling; and perhaps fertilization. It remains a challenge to determine what this role may be.

    FOOTNOTES

* This work was supported by National Institutes of Health Grants GM49899 (to Y. T.) and AR45446 (to E. E.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

|| To whom correspondence should be addressed: Dept. of Cell Biology, The Scripps Research Inst., VB-6, 10550 N. Torrey Pines Rd., La Jolla, CA 92037. Tel.: 858-784-7636; Fax: 858-784-7645; E-mail: takada@scripps.edu.

Published, JBC Papers in Press, March 6, 2002, DOI 10.1074/jbc.M200086200

    ABBREVIATIONS

The abbreviations used are: ADAM, a disintegrin and metalloprotease; CHO, Chinese hamster ovary; GST, glutathione S-transferase; EGF, epidermal growth factor; BSA, bovine serum albumin.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

1. Weskamp, G., and Blobel, C. P. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 2748-2751[Abstract/Free Full Text]
2. Wolfsberg, T. G., Straight, P. D., Gerena, R. L., Huovila, A. P., Primakoff, P., Myles, D. G., and White, J. M. (1995) Dev. Biol. 169, 378-383[CrossRef][Medline] [Order article via Infotrieve]
3. Black, R. A., and White, J. M. (1998) Curr. Opin. Cell Biol. 10, 654-659[CrossRef][Medline] [Order article via Infotrieve]
4. Wolfsberg, T., and White, J. (1996) Dev. Biol. 180, 389-401[CrossRef][Medline] [Order article via Infotrieve]
5. Almeida, E. A., Huovila, A. P., Sutherland, A. E., Stephens, L. E., Calarco, P. G., Shaw, L. M., Mercurio, A. M., Sonnenberg, A., Primakoff, P., Myles, D. G., and White, J. M. (1995) Cell 81, 1095-1104[CrossRef][Medline] [Order article via Infotrieve]
6. Evans, J. P., Schultz, R. M., and Kopf, G. S. (1995) J. Cell Sci. 108, 3267-3278[Abstract]
7. Yagami-Hiromasa, T., Sato, T., Kurisaki, T., Kamijo, K., Nabeshima, Y., and Fujisawa-Sehara, A. (1995) Nature 377, 652-656[CrossRef][Medline] [Order article via Infotrieve]
8. Gilpin, B. J., Loechel, F., Mattei, M. G., Engvall, E., Albrechtsen, R., and Wewer, U. M. (1998) J. Biol. Chem. 273, 157-166[Abstract/Free Full Text]
9. Blobel, C. P. (1997) Cell 90, 589-592[CrossRef][Medline] [Order article via Infotrieve]
10. Werb, Z., and Yan, Y. (1998) Science 282, 1279-1280[Free Full Text]
11. Buxbaum, J. D., Liu, K. N., Luo, Y., Slack, J. L., Stocking, K. L., Peschon, J. J., Johnson, R. S., Castner, B. J., Cerretti, D. P., and Black, R. A. (1998) J. Biol. Chem. 273, 27765-27767[Abstract/Free Full Text]
12. Lammich, S., Kojro, E., Postina, R., Gilbert, S., Pfeiffer, R., Jasionowski, M., Haass, C., and Fahrenholz, F. (1999) Proc. Natl. Acad. Sci. U. S. A. 96, 3922-3927[Abstract/Free Full Text]
13. Pan, D., and Rubin, G. M. (1997) Cell 90, 271-280[CrossRef][Medline] [Order article via Infotrieve]
14. Qi, H., Rand, M. D., Wu, X., Sestan, N., Wang, W., Rakic, P., Xu, T., and Artavanis-Tsakonas, S. (1999) Science 283, 91-94[Abstract/Free Full Text]
15. Izumi, Y., Hirata, M., Hasuwa, H., Iwamoto, R., Umata, T., Miyado, K., Tamai, Y., Kurisaki, T., Sehara-Fujisawa, A., Ohno, S., and Mekada, E. (1998) EMBO J. 17, 7260-7272[CrossRef][Medline] [Order article via Infotrieve]
16. Zhang, X. P., Kamata, T., Yokoyama, K., Puzon-McLaughlin, W., and Takada, Y. (1998) J. Biol. Chem. 273, 7345-7350[Abstract/Free Full Text]
17. Eto, K., Puzon-McLaughlin, W., Sheppard, D., Sehara-Fujisawa, A., Zhang, X. P., and Takada, Y. (2000) J. Biol. Chem. 275, 34922-34930[Abstract/Free Full Text]
18. Nath, D., Slocombe, P. M., Stephens, P. E., Warn, A., Hutchinson, G. R., Yamada, K. M., Docherty, A. J., and Murphy, G. (1999) J. Cell Sci. 112, 579-587[Abstract]
19. Nath, D., Slocombe, P. M., Webster, A., Stephens, P. E., Docherty, A. J., and Murphy, G. (2000) J. Cell Sci. 113, 2319-2328[Abstract]
20. Cal, S., Freije, J. M., Lopez, J. M., Takada, Y., and Lopez-Otin, C. (2000) Mol. Biol. Cell 11, 1457-1469[Abstract/Free Full Text]
21. Bridges, L. C., Tani, P. H., Hanson, K. R., Roberts, C. M., Judkins, M. B., and Bowditch, R. D. (2002) J. Biol. Chem. 277, 3784-3792[Abstract/Free Full Text]
22. Yuan, R., Primakoff, P., and Myles, D. G. (1997) J. Cell Biol. 137, 105-112[Abstract/Free Full Text]
23. Evans, J. P. (2001) Bioessays 23, 628-639[CrossRef][Medline] [Order article via Infotrieve]
24. Bigler, D., Takahashi, Y., Chen, M. S., Almeida, E. A., Osbourne, L., and White, J. M. (2000) J. Biol. Chem. 275, 11576-11584[Abstract/Free Full Text]
25. Zhu, X., Bansal, N. P., and Evans, J. P. (2000) J. Biol. Chem. 275, 7677-7683[Abstract/Free Full Text]
26. Takahashi, Y., Bigler, D., Ito, Y., and White, J. M. (2001) Mol. Biol. Cell 12, 809-820[Abstract/Free Full Text]
27. Miller, B. J., Georges-Labouesse, E., Primakoff, P., and Myles, D. G. (2000) J. Cell Biol. 149, 1289-1296[Abstract/Free Full Text]
28. Evans, J. P., Kopf, G. S., and Schultz, R. M. (1997) Dev. Biol. 187, 79-93[CrossRef][Medline] [Order article via Infotrieve]
29. Prater, C. A., Plotkin, J., Jaye, D., and Frazier, W. A. (1991) J. Cell Biol. 112, 1031-1040[Abstract/Free Full Text]
30. Takagi, J., Kamata, T., Meredith, J., Puzon-McLaughlin, W., and Takada, Y. (1997) J. Biol. Chem. 272, 19794-19800[Abstract/Free Full Text]
31. McLane, M. A., Marcinkiewicz, C., Vijay-Kumar, S., Wierzbicka-Patynowski, I., and Niewiarowski, S. (1998) Proc. Soc. Exp. Biol. Med. 219, 109-119[Abstract]
32. Palmer, E. L., Ruegg, C., Ferrando, R., Pytela, R., and Sheppard, D. (1993) J. Cell Biol. 123, 1289-1297[Abstract/Free Full Text]
33. Wang, A., Patrone, L., McDonald, J. A., and Sheppard, D. (1995) Dev. Dyn. 204, 421-431[Medline] [Order article via Infotrieve]
34. Taooka, Y., Chen, J., Yednock, T., and Sheppard, D. (1999) J. Cell Biol. 145, 413-420[Abstract/Free Full Text]
35. Evans, J. P. (1999) Front. Biosci. 4, D114-D131[Medline] [Order article via Infotrieve]
36. Guex, N., and Peitsch, M. C. (1997) Electrophoresis 18, 2714-2723[CrossRef][Medline] [Order article via Infotrieve]
37. Peitsch, M. C. (1995) Bio/Technology 13, 658-660[CrossRef]
38. Peitsch, M. C. (1996) Biochem. Soc. Trans. 24, 274-279[Medline] [Order article via Infotrieve]


Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
J. Saegusa, N. Akakura, C.-Y. Wu, C. Hoogland, Z. Ma, K. S. Lam, F.-T. Liu, Y. K. Takada, and Y. Takada
Pro-inflammatory Secretory Phospholipase A2 Type IIA Binds to Integrins {alpha}v{beta}3 and {alpha}4{beta}1 and Induces Proliferation of Monocytic Cells in an Integrin-dependent Manner
J. Biol. Chem., September 19, 2008; 283(38): 26107 - 26115.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
K. Pasten-Hidalgo, R. Hernandez-Rivas, A. L. Roa-Espitia, M. Sanchez-Gutierrez, F. Martinez-Perez, A. O. Monrroy, E. O Hernandez-Gonzalez, and A. Mujica
Presence, processing, and localization of mouse ADAM15 during sperm maturation and the role of its disintegrin domain during sperm-egg binding
Reproduction, July 1, 2008; 136(1): 41 - 51.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
G. W. deHart, T. Jin, D. E. McCloskey, A. E. Pegg, and D. Sheppard
The {alpha}9{beta}1 integrin enhances cell migration by polyamine-mediated modulation of an inward-rectifier potassium channel
PNAS, May 20, 2008; 105(20): 7188 - 7193.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Shimoda, G. Hashimoto, S. Mochizuki, E. Ikeda, N. Nagai, S. Ishida, and Y. Okada
Binding of ADAM28 to P-selectin Glycoprotein Ligand-1 Enhances P-selectin-mediated Leukocyte Adhesion to Endothelial Cells
J. Biol. Chem., August 31, 2007; 282(35): 25864 - 25874.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Stefanidakis and E. Koivunen
Cell-surface association between matrix metalloproteinases and integrins: role of the complexes in leukocyte migration and cancer progression
Blood, September 1, 2006; 108(5): 1441 - 1450.
[Abstract]